{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T07:08:20Z","timestamp":1793084900760,"version":"4.5.0"},"reference-count":7,"publisher":"American Medical Association (AMA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2026,7,21]]},"abstract":"<jats:p>This Viewpoint discusses the growing presence of synthetic peptides in enhancement drug use and outlines regulatory gaps created by the blurring of boundaries between medicine and illicit use.<\/jats:p>","DOI":"10.1001\/jama.2026.10690","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T15:30:25Z","timestamp":1781537425000},"page":"189","source":"Crossref","is-referenced-by-count":12,"title":["Illicit Injectable Peptides and Regulatory Gaps"],"prefix":"10.1001","volume":"336","author":[{"given":"Timothy","family":"Piatkowski","sequence":"first","affiliation":[{"name":"School of Public Health and Centre for Community Health and Wellbeing, Faculty of Health, Medicine, and Behavioural Sciences, The University of Queensland, Brisbane, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle T.","family":"Ganson","sequence":"additional","affiliation":[{"name":"Factor-Inwentash Faculty of Social Work, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason M.","family":"Nagata","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"12","key":"jvp260050r1","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1007\/s12178-025-09990-7","article-title":"Regeneration or risk? a narrative review of BPC-157 for musculoskeletal healing.","volume":"18","author":"McGuire","year":"2025","journal-title":"Curr Rev Musculoskelet Med"},{"issue":"10","key":"jvp260050r2","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1001\/jamapediatrics.2020.0883","article-title":"Association between legal performance-enhancing substances and use of anabolic-androgenic steroids in young adults.","volume":"174","author":"Nagata","year":"2020","journal-title":"JAMA Pediatr"},{"issue":"9","key":"jvp260050r7","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1001\/jamainternmed.2024.2525","article-title":"Semaglutide vs tirzepatide for weight loss in adults with overweight or obesity.","volume":"184","author":"Rodriguez","year":"2024","journal-title":"JAMA Intern Med"},{"key":"jvp260050r3","unstructured":"US Food and Drug Administration. Certain bulk drug substances for use in compounding that may present significant safety risks. April 22, 2026. Accessed May 13, 2026. https:\/\/www.fda.gov\/drugs\/human-drug-compounding\/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks"},{"key":"jvp260050r4","unstructured":"Therapeutic Goods Administration. Understanding your responsibilities when importing, compounding and supplying unapproved peptide products. April 13, 2026. Accessed April 24, 2026. https:\/\/www.tga.gov.au\/safety\/safety-monitoring-and-information\/safety-alerts\/understanding-your-responsibilities-when-importing-compounding-and-supplying-unapproved-peptide-products"},{"key":"jvp260050r5","unstructured":"Government of Canada. Think twice before injecting peptides bought online: unauthorized products can seriously harm you. Updated April 9, 2026. Accessed April 26, 2026. https:\/\/recalls-rappels.canada.ca\/en\/alert-recall\/think-twice-injecting-peptides-bought-online-unauthorized-products-can-seriously-harm"},{"key":"jvp260050r6","unstructured":"Jewett? C, Blum? D. Heeding Kennedy\u2019s wishes, FDA is expected to lift restriction on peptides. New York Times. March 31, 2026. Accessed April 24, 2026. https:\/\/www.nytimes.com\/2026\/03\/31\/health\/peptide-ban-fda-rfk-jr.html"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2850449\/jama_piatkowski_2026_vp_260050_1783976420.21748.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T15:00:35Z","timestamp":1784646035000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2850449"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,21]]},"references-count":7,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,7,21]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2026.10690","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,21]]}}}